Table 3 Changes in functional, cardiovascular, and patient-reported endpoints in DHI participants at 3 months
| Â | DHI Group | ||||
|---|---|---|---|---|---|
Baseline Mean ± SD | 3-Month Follow Up Mean ± SD | Patients with Full Data N | Within-Group Difference MD (95% CI) | P | |
6-min walk distance, meters | 441 ± 133 | 463 ± 135 | 97 | 29 (10 to 49) |  < 0.01 |
Weekly activity, steps | 30,616 ± 23,008 | 39,983 ± 29,403 | 93 |  + 9367 (1412 to 10,162) | 0.01 |
Total cholesterol, mg/dL | 148 ± 44 | 136 ± 35 | 146 | -10 (-16 to -4) |  < 0.01 |
LDL cholesterol, mg/dL | 81 ± 39 | 71 ± 32 | 145 | -11 (-17 to -5) |  < 0.01 |
HDL cholesterol, mg/dL | 40 ± 11 | 40 ± 10 | 146 | 0.5 (-0.7 to 1.6) | 0.5 |
Glycated hemoglobin, % | 6.7 ± 1.6 | 6.6 ± 1.5 | 132 | 0.1 (-0.1 to 0.5) | 0.17 |
Systolic blood pressure, mmHg | 129 ± 17 | 125 ± 18 | 211 | -4 (-7 to -2) | 0.01 |
Diastolic blood pressure, mmHg | 79 ± 11 | 76 ± 11 | 211 | -2 (-3.9 to 0.2) | 0.03 |
BMI | 31.8 ± 6.2 | 31 ± 6 | 213 | -0.4 (-0.7 to -0.2) |  < 0.01 |
Current smoker | 15% | 10% | 214 | -5% (-8% to -2%) |  < 0.01 |
DASI | 33 ± 16.4 | 41 ± 15.5 | 142 | 7 (5 to 9) |  < 0.01 |
PHQ-9 | 6.1 ± 5.3 | 4.4 ± 5.2 | 141 | -1.7 (-2.4 to -1.1) |  < 0.01 |